The Emerging Antimicrobial Protection Hypothesis of Alzheimer's Disease

Event Date: 
Wednesday, April 17, 2019
12:00 p.m. - 1:00 p.m.

Please join Accelerate Cure/Treatments for Alzheimer’s disease (ACT-AD) for an hour-long webinar with Dr. Rudolph Tanzi and Dr. Robert Moir, two preeminent researchers in Alzheimer’s disease, for a presentation on the latest cutting-edge research behind the antimicrobial protection hypothesis of Alzheimer’s disease.

Click here to register for the webinar!

Webinar Speakers:

Rudolph Tanzi, Ph

Joseph P. and Rose F. Kennedy Professor of Neurology

Harvard University


Robert Moir, PhD

Genetics and Aging Research Unit

Massachusetts General Hospital

Media Contacts

Terri Schwartzbeck
Senior Manager of Communications 

If concerted, long-term investments in research are not made, America will lose an entire generation of young scientists.
Brenda Canine, PhD; McLaughlin Research Institute, Montana